Predictor | Coeff. | SE | Wald | P-value | HR | 95% CI for HR | |
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
Gender | 0.015 | 0.190 | 0.007 | 0.935 | 1.02 | 0.700 | 1.47 |
Ethnicity | 0.923 | 0.820 | |||||
European v Māori/Pasifika | -0.797 | 1.08 | 0.602 | 0.438 | 0.451 | 0.060 | 3.38 |
European v Asian | -7.23 | 226.3 | 0.001 | 0.975 | 0.001 | 1.85 × 10− 196 | 2.85 × 10189 |
European v MELAA | -1.39 | 1.484 | 0.888 | 0.346 | 0.247 | 0.013 | 4.53 |
Physical Activity (scale 1–4)$$ | -0.309 | 0.069 | 20.1 | 7.16 × 10− 6 | 0.734 | 0.642 | 0.840 |
Previous MI | 0.590 | 0.167 | 12.5 | 4.06 × 10− 4 | 1.803 | 1.301 | 2.501 |
Age | 0.064 | 0.012 | 30.6 | 3.08 × 10− 8 | 1.07 | 1.042 | 1.09 |
Body mass index | -0.053 | 0.021 | 6.09 | 0.014 | 0.948 | 0.909 | 0.989 |
Urate | 1.52 | 0.840 | 3.27 | 0.071 | 4.57 | 0.881 | 23.7 |
Creatinine | 0.005 | 0.001 | 11.9 | 0.001 | 1.005 | 1.002 | 1.008 |
Beta blocker | -0.128 | 0.230 | 0.310 | 0.578 | 0.880 | 0.561 | 1.38 |
Statin | -0.195 | 0.199 | 0.962 | 0.327 | 0.823 | 0.557 | 1.22 |
Log10 NTproBNP$ | 0.860 | 0.253 | 11.5 | 0.001 | 2.36 | 1.44 | 3.88 |
Log10 VEGF-A$ | 0.974 | 0.295 | 10.9 | 0.001 | 2.65 | 1.49 | 4.73 |
rs6921438 genotype | 7.34 | 0.026 | |||||
GG v GA | -0.199 | 0.477 | 0.175 | 0.676 | 0.819 | 0.322 | 2.09 |
GG v AA | -1.47 | 0.649 | 5.13 | 0.024 | 0.230 | 0.064 | 0.820 |
rs7767396 genotype | 10.1 | 0.006 | |||||
AA v AG | 0.074 | 0.488 | 0.023 | 0.879 | 1.08 | 0.414 | 2.804 |
AA v GG | 1.56 | 0.646 | 5.82 | 0.016 | 4.76 | 1.34 | 16.9 |
Time to sampling | 0.003 | 0.008 | 0.202 | 0.653 | 1.003 | 0.988 | 1.02 |